From Russia with review [RSABE / ABEL]

posted by mittyri – Russia, 2019-12-04 11:29 (502 d 06:15 ago) – Posting: # 20917
Views: 3,615

(edited by mittyri on 2019-12-04 11:55)

Hi Helmut,

» Since three authors are members of the “Scientific Centre for Expert Evaluation of Medicinal Products of the Ministry of Health of the Russian Federation” (and the first one is the head of the department): Are the conclusions really a recommendation?

I would translate the sentence in the last paragraph before conclusion as:
Currently the discussions related to reference scaling modification are going on.
Conclusion says that it is just a review, not a recommendation.

Kind regards,
Mittyri

Complete thread:

Activity
 Admin contact
21,419 posts in 4,475 threads, 1,510 registered users;
online 10 (0 registered, 10 guests [including 2 identified bots]).
Forum time: Monday 18:45 CEST (Europe/Vienna)

There is one certainty in drug development
and statistics that one can depend on:
the data are always late.    Scott Patterson and Byron Jones

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5